Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of valescent plasma to the standard of care in patients hospitalized with COVID- nCoV (DAWn-Plasma) trial.

Published on sciensano.be (https://www.sciensano.be)

Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of valescent plasma to the standard of care in patients hospitalized with COVID- nCoV (DAWn-Plasma) trial.

Health and disease monitoring

Peer reviewed scientific article

English

SCIENSANO

Authors

Timothy Devos [1]

Keywords

Associated health topics:

Health and disease monitoring [2]

Source URL:https://www.sciensano.be/en/biblio/correction-a-randomized-multicentre-open-label-phase-ii-proof-concept-trial-investigating-clinical

Links
[1] https://www.sciensano.be/en/biblio?f%5Bauthor%5D=182858&f%5Bsearch%5D=Timothy%20Devos [2] https://www.sciensano.be/en/health-topics/health-and-disease-monitoring